224 related articles for article (PubMed ID: 29110121)
1. [Nanoparticles as drug delivery systems in ophthalmology].
Löscher M; Hurst J; Strudel L; Spitzer MS; Schnichels S
Ophthalmologe; 2018 Mar; 115(3):184-189. PubMed ID: 29110121
[TBL] [Abstract][Full Text] [Related]
2. Nano-ophthalmology: Applications and considerations.
Kamaleddin MA
Nanomedicine; 2017 May; 13(4):1459-1472. PubMed ID: 28232288
[TBL] [Abstract][Full Text] [Related]
3. Nanomaterials for ocular drug delivery.
Liu S; Jones L; Gu FX
Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445
[TBL] [Abstract][Full Text] [Related]
4. Progress in drug formulation design and delivery of medicinal substances used in ophthalmology.
Wróblewska KB; Jadach B; Muszalska-Kolos I
Int J Pharm; 2021 Sep; 607():121012. PubMed ID: 34400274
[TBL] [Abstract][Full Text] [Related]
5. Advance of the application of nano-controlled release system in ophthalmic drug delivery.
Wang X; Wang S; Zhang Y
Drug Deliv; 2016 Oct; 23(8):2897-2901. PubMed ID: 26635087
[TBL] [Abstract][Full Text] [Related]
6. Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye.
Wang Y; Xu X; Gu Y; Cheng Y; Cao F
Expert Opin Drug Deliv; 2018 Jul; 15(7):687-701. PubMed ID: 29985660
[TBL] [Abstract][Full Text] [Related]
7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
8. Topical application of polymeric nanomicelles in ophthalmology: a review on research efforts for the noninvasive delivery of ocular therapeutics.
Grimaudo MA; Pescina S; Padula C; Santi P; Concheiro A; Alvarez-Lorenzo C; Nicoli S
Expert Opin Drug Deliv; 2019 Apr; 16(4):397-413. PubMed ID: 30889977
[TBL] [Abstract][Full Text] [Related]
9. Ten Years of Knowledge of Nano-Carrier Based Drug Delivery Systems in Ophthalmology: Current Evidence, Challenges, and Future Prospective.
Zhang J; Jiao J; Niu M; Gao X; Zhang G; Yu H; Yang X; Liu L
Int J Nanomedicine; 2021; 16():6497-6530. PubMed ID: 34588777
[TBL] [Abstract][Full Text] [Related]
10. Application of lipid nanoparticles to ocular drug delivery.
Battaglia L; Serpe L; Foglietta F; Muntoni E; Gallarate M; Del Pozo Rodriguez A; Solinis MA
Expert Opin Drug Deliv; 2016 Dec; 13(12):1743-1757. PubMed ID: 27291069
[TBL] [Abstract][Full Text] [Related]
11. Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma.
Wu KY; Wang XC; Anderson M; Tran SD
Molecules; 2024 May; 29(10):. PubMed ID: 38792122
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles as safe and effective delivery systems of antifungal agents: Achievements and challenges.
Soliman GM
Int J Pharm; 2017 May; 523(1):15-32. PubMed ID: 28323096
[TBL] [Abstract][Full Text] [Related]
13. Lipid nanoparticles as drug/gene delivery systems to the retina.
del Pozo-Rodríguez A; Delgado D; Gascón AR; Solinís MÁ
J Ocul Pharmacol Ther; 2013 Mar; 29(2):173-88. PubMed ID: 23286300
[TBL] [Abstract][Full Text] [Related]
14. DNA nanoparticles for ophthalmic drug delivery.
Willem de Vries J; Schnichels S; Hurst J; Strudel L; Gruszka A; Kwak M; Bartz-Schmidt KU; Spitzer MS; Herrmann A
Biomaterials; 2018 Mar; 157():98-106. PubMed ID: 29258013
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye.
Bisht R; Jaiswal JK; Rupenthal ID
Med Hypotheses; 2017 Jun; 103():5-9. PubMed ID: 28571808
[TBL] [Abstract][Full Text] [Related]
16. General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.
Wakaskar RR
J Drug Target; 2018 Apr; 26(4):311-318. PubMed ID: 28797169
[TBL] [Abstract][Full Text] [Related]
17. Applications of nanoparticles in ophthalmology.
Diebold Y; Calonge M
Prog Retin Eye Res; 2010 Nov; 29(6):596-609. PubMed ID: 20826225
[TBL] [Abstract][Full Text] [Related]
18. Lipid-Based Nanoparticulate Systems for the Ocular Delivery of Bioactives with Anti-Inflammatory Properties.
Ana RD; Fonseca J; Karczewski J; Silva AM; Zielińska A; Souto EB
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292951
[TBL] [Abstract][Full Text] [Related]
19. Dendrimeric systems and their applications in ocular drug delivery.
Yavuz B; Pehlivan SB; Unlü N
ScientificWorldJournal; 2013; 2013():732340. PubMed ID: 24396306
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases.
Cacciatore I; Ciulla M; Fornasari E; Marinelli L; Di Stefano A
Expert Opin Drug Deliv; 2016 Aug; 13(8):1121-31. PubMed ID: 27073977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
